

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 6.28852367 |
| 2 | regulation of vitamin D biosynthetic process (GO:0060556) | 5.68140907 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.35737070 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.35737070 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.35737070 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.35737070 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.35737070 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 5.35737070 |
| 9 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.19874771 |
| 10 | response to peptidoglycan (GO:0032494) | 4.98975472 |
| 11 | respiratory burst (GO:0045730) | 4.68909667 |
| 12 | granulocyte activation (GO:0036230) | 4.59171740 |
| 13 | regulation of vitamin metabolic process (GO:0030656) | 4.47529028 |
| 14 | macrophage activation involved in immune response (GO:0002281) | 4.36924871 |
| 15 | neutrophil activation (GO:0042119) | 4.34982398 |
| 16 | wound healing, spreading of epidermal cells (GO:0035313) | 4.33861110 |
| 17 | superoxide anion generation (GO:0042554) | 4.30434109 |
| 18 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.26361581 |
| 19 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.23509972 |
| 20 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.13607381 |
| 21 | leukocyte aggregation (GO:0070486) | 4.07688917 |
| 22 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.00218252 |
| 23 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.94929637 |
| 24 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.91810228 |
| 25 | reactive oxygen species biosynthetic process (GO:1903409) | 3.83094567 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.80866008 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 3.78337994 |
| 28 | response to muramyl dipeptide (GO:0032495) | 3.73337694 |
| 29 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.70323381 |
| 30 | regulation of chronic inflammatory response (GO:0002676) | 3.69687023 |
| 31 | positive regulation of interferon-alpha production (GO:0032727) | 3.69196895 |
| 32 | regulation of mast cell degranulation (GO:0043304) | 3.68764529 |
| 33 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.66162621 |
| 34 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.65090444 |
| 35 | glycosphingolipid catabolic process (GO:0046479) | 3.62466366 |
| 36 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.59489634 |
| 37 | positive regulation of mast cell degranulation (GO:0043306) | 3.59489634 |
| 38 | response to host immune response (GO:0052572) | 3.58570420 |
| 39 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.58570420 |
| 40 | NIK/NF-kappaB signaling (GO:0038061) | 3.55345052 |
| 41 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.55305372 |
| 42 | T-helper 1 type immune response (GO:0042088) | 3.54294245 |
| 43 | cellular extravasation (GO:0045123) | 3.54128931 |
| 44 | positive regulation of mast cell activation (GO:0033005) | 3.53436281 |
| 45 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.51690300 |
| 46 | regulation of interferon-alpha production (GO:0032647) | 3.51558238 |
| 47 | myeloid cell activation involved in immune response (GO:0002275) | 3.49838193 |
| 48 | negative regulation of mast cell activation (GO:0033004) | 3.49717904 |
| 49 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.48635206 |
| 50 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.47871021 |
| 51 | oligosaccharide catabolic process (GO:0009313) | 3.46542064 |
| 52 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.44291639 |
| 53 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.38953729 |
| 54 | positive regulation of heat generation (GO:0031652) | 3.38674939 |
| 55 | regulation of chemokine biosynthetic process (GO:0045073) | 3.38629609 |
| 56 | regulation of mast cell activation (GO:0033003) | 3.35827669 |
| 57 | regulation of mononuclear cell migration (GO:0071675) | 3.35323697 |
| 58 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.30664836 |
| 59 | macrophage activation (GO:0042116) | 3.28479560 |
| 60 | response to protozoan (GO:0001562) | 3.28441201 |
| 61 | regulation of fever generation (GO:0031620) | 3.27133448 |
| 62 | germinal center formation (GO:0002467) | 3.26558910 |
| 63 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.26390743 |
| 64 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.25031466 |
| 65 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.24196188 |
| 66 | glycolipid catabolic process (GO:0019377) | 3.23815761 |
| 67 | type I interferon signaling pathway (GO:0060337) | 3.23490019 |
| 68 | cellular response to type I interferon (GO:0071357) | 3.23490019 |
| 69 | regulation of heat generation (GO:0031650) | 3.23437469 |
| 70 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.23271203 |
| 71 | cellular response to lipopolysaccharide (GO:0071222) | 3.23149565 |
| 72 | wound healing, spreading of cells (GO:0044319) | 3.22852347 |
| 73 | detection of molecule of bacterial origin (GO:0032490) | 3.22386466 |
| 74 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.22166621 |
| 75 | response to host (GO:0075136) | 3.22166621 |
| 76 | response to host defenses (GO:0052200) | 3.22166621 |
| 77 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.20496649 |
| 78 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.18317305 |
| 79 | response to type I interferon (GO:0034340) | 3.17983382 |
| 80 | negative regulation of interleukin-12 production (GO:0032695) | 3.15423246 |
| 81 | defense response to protozoan (GO:0042832) | 3.15042235 |
| 82 | cellular response to molecule of bacterial origin (GO:0071219) | 3.14212531 |
| 83 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.12949570 |
| 84 | neutrophil chemotaxis (GO:0030593) | 3.04621697 |
| 85 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.04501946 |
| 86 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.03632013 |
| 87 | regulation of leukocyte degranulation (GO:0043300) | 3.03262912 |
| 88 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.02905347 |
| 89 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.02712540 |
| 90 | positive regulation of acute inflammatory response (GO:0002675) | 3.02325432 |
| 91 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.02262132 |
| 92 | eosinophil chemotaxis (GO:0048245) | 3.01616512 |
| 93 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.01062007 |
| 94 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.99517708 |
| 95 | negative regulation of lipid storage (GO:0010888) | 2.98637864 |
| 96 | regulation of monocyte chemotaxis (GO:0090025) | 2.98401464 |
| 97 | positive regulation of leukocyte degranulation (GO:0043302) | 2.97497633 |
| 98 | leukocyte cell-cell adhesion (GO:0007159) | 2.97329023 |
| 99 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.96593450 |
| 100 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.96193374 |
| 101 | neutrophil migration (GO:1990266) | 2.95716128 |
| 102 | myeloid dendritic cell differentiation (GO:0043011) | 2.95013497 |
| 103 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.94758750 |
| 104 | microglial cell activation (GO:0001774) | 2.93479789 |
| 105 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.93172560 |
| 106 | eosinophil migration (GO:0072677) | 2.92280538 |
| 107 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.91217336 |
| 108 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.91184466 |
| 109 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.90178503 |
| 110 | positive regulation of interferon-beta production (GO:0032728) | 2.89074594 |
| 111 | monocyte chemotaxis (GO:0002548) | 2.87739152 |
| 112 | positive regulation of type 2 immune response (GO:0002830) | 2.87340565 |
| 113 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.86165333 |
| 114 | natural killer cell mediated immunity (GO:0002228) | 2.86165333 |
| 115 | phagosome maturation (GO:0090382) | 2.85458261 |
| 116 | ceramide catabolic process (GO:0046514) | 2.85262205 |
| 117 | regulation of NF-kappaB import into nucleus (GO:0042345) | 2.84803888 |
| 118 | myeloid leukocyte activation (GO:0002274) | 2.84667595 |
| 119 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.84156871 |
| 120 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.82197247 |
| 121 | regulation of interleukin-6 production (GO:0032675) | 2.82184358 |
| 122 | regulation of podosome assembly (GO:0071801) | 2.81829911 |
| 123 | regulation of interleukin-12 production (GO:0032655) | 2.80726244 |
| 124 | low-density lipoprotein particle clearance (GO:0034383) | 2.80657777 |
| 125 | positive regulation of interleukin-6 production (GO:0032755) | 2.80492852 |
| 126 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.80238512 |
| 127 | positive regulation of chemokine production (GO:0032722) | 2.79389850 |
| 128 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.77520326 |
| 129 | decidualization (GO:0046697) | 2.76962744 |
| 130 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.75359694 |
| 131 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.74596058 |
| 132 | myeloid dendritic cell activation (GO:0001773) | 2.74450514 |
| 133 | myeloid cell homeostasis (GO:0002262) | 2.74092952 |
| 134 | cellular response to biotic stimulus (GO:0071216) | 2.73084653 |
| 135 | B cell mediated immunity (GO:0019724) | 2.73051891 |
| 136 | neutrophil mediated immunity (GO:0002446) | 2.72899762 |
| 137 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.72875049 |
| 138 | dendritic cell differentiation (GO:0097028) | 2.72852654 |
| 139 | amino sugar catabolic process (GO:0046348) | 2.71909587 |
| 140 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.70169130 |
| 141 | regulation of macrophage cytokine production (GO:0010935) | 2.69994943 |
| 142 | positive regulation of antigen processing and presentation (GO:0002579) | 2.69766852 |
| 143 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.68680455 |
| 144 | regulation of growth of symbiont in host (GO:0044126) | 2.68680455 |
| 145 | negative regulation of growth of symbiont in host (GO:0044130) | 2.68680455 |
| 146 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.68680455 |
| 147 | leukocyte mediated cytotoxicity (GO:0001909) | 2.68452085 |
| 148 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.68196624 |
| 149 | virion attachment to host cell (GO:0019062) | 2.66127156 |
| 150 | adhesion of symbiont to host cell (GO:0044650) | 2.66127156 |
| 151 | cell adhesion mediated by integrin (GO:0033627) | 2.66114453 |
| 152 | lymphocyte chemotaxis (GO:0048247) | 2.65974368 |
| 153 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.65843061 |
| 154 | membrane lipid catabolic process (GO:0046466) | 2.65781674 |
| 155 | detection of other organism (GO:0098543) | 2.65509322 |
| 156 | granulocyte chemotaxis (GO:0071621) | 2.65444270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.33345645 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.03495866 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.92508727 |
| 4 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.82345435 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.79758501 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.79580557 |
| 7 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.51150113 |
| 8 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.45701967 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.39479543 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.13050946 |
| 11 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.08997236 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.01219358 |
| 13 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.83508502 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.82506408 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.71552373 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.65738829 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.50881384 |
| 18 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.44788467 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.41583906 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39606496 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.37915688 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.28572214 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.19688937 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13760704 |
| 25 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.10918857 |
| 26 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.02744007 |
| 27 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.86173971 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.82447036 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.80598041 |
| 30 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.74617302 |
| 31 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.71254145 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71085433 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.69224618 |
| 34 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.62493366 |
| 35 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61542019 |
| 36 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.60810536 |
| 37 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.60690968 |
| 38 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.59630672 |
| 39 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.57751887 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.57234419 |
| 41 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.56752862 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.55477095 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.55024181 |
| 44 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.52079589 |
| 45 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.52079589 |
| 46 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.49244314 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.47740923 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44914676 |
| 49 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.44621650 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42705019 |
| 51 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.41713299 |
| 52 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.40174704 |
| 53 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40100502 |
| 54 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37631162 |
| 55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.36536551 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.36133019 |
| 57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32822551 |
| 58 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28309949 |
| 59 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.27463622 |
| 60 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27367038 |
| 61 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27037652 |
| 62 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.24017624 |
| 63 | MYB_26560356_Chip-Seq_TH1_Human | 1.24015812 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23780995 |
| 65 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21081534 |
| 66 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20611155 |
| 67 | CJUN_26792858_Chip-Seq_BT549_Human | 1.18978748 |
| 68 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18725305 |
| 69 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18489091 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18339711 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.16961203 |
| 72 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.16111895 |
| 73 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.15038754 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13174285 |
| 75 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11718751 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.11432063 |
| 77 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10840182 |
| 78 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10840182 |
| 79 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10576125 |
| 80 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.10405769 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06809598 |
| 82 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05285572 |
| 83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02277975 |
| 84 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.01066118 |
| 85 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.00788233 |
| 86 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.99968068 |
| 87 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.99492573 |
| 88 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98141874 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97710505 |
| 90 | GATA1_22025678_ChIP-Seq_K562_Human | 0.97270170 |
| 91 | * KDM2B_26808549_Chip-Seq_DND41_Human | 0.95542411 |
| 92 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95315047 |
| 93 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95068010 |
| 94 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.94738904 |
| 95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94713237 |
| 96 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94698430 |
| 97 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.93748103 |
| 98 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.93683166 |
| 99 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92027402 |
| 100 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.91431884 |
| 101 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90712400 |
| 102 | MAF_26560356_Chip-Seq_TH2_Human | 0.89301727 |
| 103 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.87666962 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86742701 |
| 105 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.85249183 |
| 106 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84700688 |
| 107 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.83856071 |
| 108 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82511505 |
| 109 | ATF3_27146783_Chip-Seq_COLON_Human | 0.81942358 |
| 110 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.81832389 |
| 111 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.81726439 |
| 112 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.81624723 |
| 113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81265862 |
| 114 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.80909023 |
| 115 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.79726907 |
| 116 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.76660216 |
| 117 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76397284 |
| 118 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.76018073 |
| 119 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.75888759 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 4.50702079 |
| 2 | MP0003303_peritoneal_inflammation | 3.94266709 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.73027946 |
| 4 | MP0009785_altered_susceptibility_to | 3.28406268 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.28204301 |
| 6 | * MP0002419_abnormal_innate_immunity | 3.16640744 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.92590050 |
| 8 | MP0003724_increased_susceptibility_to | 2.83613832 |
| 9 | MP0001533_abnormal_skeleton_physiology | 2.70998123 |
| 10 | * MP0005025_abnormal_response_to | 2.58330025 |
| 11 | MP0006082_CNS_inflammation | 2.52969890 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.38875981 |
| 13 | MP0000343_altered_response_to | 2.38874361 |
| 14 | MP0004510_myositis | 2.30591780 |
| 15 | MP0001790_abnormal_immune_system | 2.23559916 |
| 16 | MP0005387_immune_system_phenotype | 2.23559916 |
| 17 | * MP0002723_abnormal_immune_serum | 2.11586475 |
| 18 | MP0002405_respiratory_system_inflammati | 2.08573783 |
| 19 | MP0003448_altered_tumor_morphology | 2.07156927 |
| 20 | MP0001800_abnormal_humoral_immune | 2.02809087 |
| 21 | MP0002933_joint_inflammation | 1.97093119 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 1.96061587 |
| 23 | MP0000685_abnormal_immune_system | 1.94536396 |
| 24 | * MP0001819_abnormal_immune_cell | 1.94178138 |
| 25 | MP0005464_abnormal_platelet_physiology | 1.93977288 |
| 26 | * MP0002420_abnormal_adaptive_immunity | 1.92034975 |
| 27 | MP0005451_abnormal_body_composition | 1.89426631 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.87990330 |
| 29 | MP0009764_decreased_sensitivity_to | 1.86604086 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.82236779 |
| 31 | MP0003566_abnormal_cell_adhesion | 1.82083966 |
| 32 | MP0000858_altered_metastatic_potential | 1.80800888 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.78922133 |
| 34 | MP0009278_abnormal_bone_marrow | 1.75855263 |
| 35 | MP0004947_skin_inflammation | 1.73142197 |
| 36 | MP0002998_abnormal_bone_remodeling | 1.72604389 |
| 37 | * MP0001845_abnormal_inflammatory_respons | 1.71848658 |
| 38 | MP0005671_abnormal_response_to | 1.69533500 |
| 39 | MP0005390_skeleton_phenotype | 1.69174980 |
| 40 | MP0002332_abnormal_exercise_endurance | 1.61498784 |
| 41 | MP0003075_altered_response_to | 1.60897799 |
| 42 | * MP0001853_heart_inflammation | 1.55350108 |
| 43 | MP0005166_decreased_susceptibility_to | 1.55087360 |
| 44 | MP0005167_abnormal_blood-brain_barrier | 1.54663890 |
| 45 | MP0003279_aneurysm | 1.53755651 |
| 46 | MP0003828_pulmonary_edema | 1.52231202 |
| 47 | MP0005023_abnormal_wound_healing | 1.51410920 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.51194840 |
| 49 | MP0008438_abnormal_cutaneous_collagen | 1.50835775 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.48896600 |
| 51 | MP0005164_abnormal_response_to | 1.48639019 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 1.39020935 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.37232554 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.37232554 |
| 55 | MP0003091_abnormal_cell_migration | 1.35670281 |
| 56 | * MP0008469_abnormal_protein_level | 1.34949028 |
| 57 | MP0000716_abnormal_immune_system | 1.30224272 |
| 58 | MP0003300_gastrointestinal_ulcer | 1.27437815 |
| 59 | MP0003690_abnormal_glial_cell | 1.27127098 |
| 60 | MP0005076_abnormal_cell_differentiation | 1.25563335 |
| 61 | MP0003705_abnormal_hypodermis_morpholog | 1.24809370 |
| 62 | MP0002006_tumorigenesis | 1.23122596 |
| 63 | MP0002877_abnormal_melanocyte_morpholog | 1.21819531 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.21454762 |
| 65 | MP0004782_abnormal_surfactant_physiolog | 1.17548955 |
| 66 | MP0003186_abnormal_redox_activity | 1.16364384 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.16176782 |
| 68 | MP0002398_abnormal_bone_marrow | 1.15874820 |
| 69 | MP0001851_eye_inflammation | 1.14687308 |
| 70 | MP0001542_abnormal_bone_strength | 1.13330674 |
| 71 | MP0003195_calcinosis | 1.13049818 |
| 72 | MP0005165_increased_susceptibility_to | 1.11769441 |
| 73 | MP0003795_abnormal_bone_structure | 1.11345442 |
| 74 | MP0008004_abnormal_stomach_pH | 1.10435961 |
| 75 | MP0003453_abnormal_keratinocyte_physiol | 1.09242234 |
| 76 | MP0001958_emphysema | 1.07086233 |
| 77 | MP0002429_abnormal_blood_cell | 1.06156298 |
| 78 | MP0000689_abnormal_spleen_morphology | 1.03032188 |
| 79 | MP0000249_abnormal_blood_vessel | 0.98802928 |
| 80 | MP0004883_abnormal_blood_vessel | 0.96427454 |
| 81 | MP0000767_abnormal_smooth_muscle | 0.95133452 |
| 82 | MP0002722_abnormal_immune_system | 0.93707985 |
| 83 | MP0000569_abnormal_digit_pigmentation | 0.91878326 |
| 84 | MP0005310_abnormal_salivary_gland | 0.91230661 |
| 85 | MP0003950_abnormal_plasma_membrane | 0.91082949 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 0.90710949 |
| 87 | MP0000920_abnormal_myelination | 0.90611345 |
| 88 | MP0009840_abnormal_foam_cell | 0.88332576 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.88024566 |
| 90 | MP0003329_amyloid_beta_deposits | 0.85633502 |
| 91 | MP0004808_abnormal_hematopoietic_stem | 0.84456587 |
| 92 | MP0010307_abnormal_tumor_latency | 0.82917853 |
| 93 | MP0001879_abnormal_lymphatic_vessel | 0.78621728 |
| 94 | MP0001663_abnormal_digestive_system | 0.76141881 |
| 95 | MP0000604_amyloidosis | 0.75704633 |
| 96 | MP0009763_increased_sensitivity_to | 0.75400356 |
| 97 | MP0005257_abnormal_intraocular_pressure | 0.75363334 |
| 98 | MP0002295_abnormal_pulmonary_circulatio | 0.74440782 |
| 99 | MP0000490_abnormal_crypts_of | 0.72639039 |
| 100 | MP0006054_spinal_hemorrhage | 0.72208902 |
| 101 | MP0002254_reproductive_system_inflammat | 0.71477082 |
| 102 | MP0008874_decreased_physiological_sensi | 0.70924981 |
| 103 | MP0002113_abnormal_skeleton_development | 0.70716935 |
| 104 | MP0000750_abnormal_muscle_regeneration | 0.68810497 |
| 105 | MP0005595_abnormal_vascular_smooth | 0.65977642 |
| 106 | MP0002138_abnormal_hepatobiliary_system | 0.65520654 |
| 107 | MP0002136_abnormal_kidney_physiology | 0.64191164 |
| 108 | MP0001243_abnormal_dermal_layer | 0.62849618 |
| 109 | MP0000733_abnormal_muscle_development | 0.62339587 |
| 110 | MP0005174_abnormal_tail_pigmentation | 0.60324624 |
| 111 | MP0005275_abnormal_skin_tensile | 0.60314471 |
| 112 | MP0005647_abnormal_sex_gland | 0.59792235 |
| 113 | MP0001873_stomach_inflammation | 0.57235845 |
| 114 | MP0008260_abnormal_autophagy | 0.57151097 |
| 115 | MP0004272_abnormal_basement_membrane | 0.56453955 |
| 116 | MP0002277_abnormal_respiratory_mucosa | 0.52035516 |
| 117 | MP0001849_ear_inflammation | 0.51834400 |
| 118 | MP0002837_dystrophic_cardiac_calcinosis | 0.51280543 |
| 119 | MP0001216_abnormal_epidermal_layer | 0.50742434 |
| 120 | MP0005319_abnormal_enzyme/_coenzyme | 0.50725195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 6.89483334 |
| 2 | Recurrent abscess formation (HP:0002722) | 6.57773907 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.89203796 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.80292038 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.74251268 |
| 6 | Mediastinal lymphadenopathy (HP:0100721) | 4.53081833 |
| 7 | Loss of speech (HP:0002371) | 4.46424395 |
| 8 | Stomatitis (HP:0010280) | 3.99904151 |
| 9 | Epiphyseal dysplasia (HP:0002656) | 3.91774973 |
| 10 | Gingivitis (HP:0000230) | 3.76039074 |
| 11 | Obstructive lung disease (HP:0006536) | 3.66694031 |
| 12 | Chronic obstructive pulmonary disease (HP:0006510) | 3.66694031 |
| 13 | Mutism (HP:0002300) | 3.63646625 |
| 14 | Nuclear cataract (HP:0100018) | 3.57133343 |
| 15 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.49580721 |
| 16 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.49580721 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.49580721 |
| 18 | Recurrent skin infections (HP:0001581) | 3.48994691 |
| 19 | Neurofibrillary tangles (HP:0002185) | 3.46961274 |
| 20 | Amyloidosis (HP:0011034) | 3.32718072 |
| 21 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.26429508 |
| 22 | Mucopolysacchariduria (HP:0008155) | 3.26429508 |
| 23 | Irregular epiphyses (HP:0010582) | 3.23314600 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.21396486 |
| 25 | Increased cerebral lipofuscin (HP:0011813) | 3.19732287 |
| 26 | Vacuolated lymphocytes (HP:0001922) | 3.18129507 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.14353565 |
| 28 | Cellulitis (HP:0100658) | 3.13850020 |
| 29 | Myositis (HP:0100614) | 3.12839626 |
| 30 | Orchitis (HP:0100796) | 3.10922928 |
| 31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.05884060 |
| 32 | Interstitial pulmonary disease (HP:0006530) | 3.01145116 |
| 33 | Cupped ribs (HP:0000887) | 2.97891815 |
| 34 | Increased serum ferritin (HP:0003281) | 2.95034398 |
| 35 | Axonal loss (HP:0003447) | 2.91311685 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 2.84173513 |
| 37 | Keratoconjunctivitis sicca (HP:0001097) | 2.83369722 |
| 38 | Small epiphyses (HP:0010585) | 2.83049307 |
| 39 | Vitreoretinal degeneration (HP:0000655) | 2.82926527 |
| 40 | Apathy (HP:0000741) | 2.82394940 |
| 41 | Cervical subluxation (HP:0003308) | 2.77716335 |
| 42 | Retrobulbar optic neuritis (HP:0100654) | 2.77075454 |
| 43 | Optic neuritis (HP:0100653) | 2.77075454 |
| 44 | Diminished motivation (HP:0000745) | 2.76873788 |
| 45 | Recurrent pneumonia (HP:0006532) | 2.68215311 |
| 46 | Vertebral compression fractures (HP:0002953) | 2.63734439 |
| 47 | Flat capital femoral epiphysis (HP:0003370) | 2.62021954 |
| 48 | Absent frontal sinuses (HP:0002688) | 2.61671150 |
| 49 | Osteolytic defects of the hand bones (HP:0009699) | 2.61587246 |
| 50 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.61587246 |
| 51 | Progressive neurologic deterioration (HP:0002344) | 2.56530833 |
| 52 | Keratoconjunctivitis (HP:0001096) | 2.56104047 |
| 53 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.54908152 |
| 54 | Flat acetabular roof (HP:0003180) | 2.52611365 |
| 55 | Glomerulonephritis (HP:0000099) | 2.51204712 |
| 56 | Systemic lupus erythematosus (HP:0002725) | 2.50671840 |
| 57 | Pustule (HP:0200039) | 2.49076740 |
| 58 | Myocardial infarction (HP:0001658) | 2.47906216 |
| 59 | Hepatosplenomegaly (HP:0001433) | 2.45384316 |
| 60 | Neuronal loss in central nervous system (HP:0002529) | 2.44219351 |
| 61 | Cerebral inclusion bodies (HP:0100314) | 2.44043197 |
| 62 | Purpura (HP:0000979) | 2.43974973 |
| 63 | Urticaria (HP:0001025) | 2.41356410 |
| 64 | Premature rupture of membranes (HP:0001788) | 2.36971051 |
| 65 | Thick nail (HP:0001805) | 2.36969256 |
| 66 | Upper motor neuron abnormality (HP:0002127) | 2.34206156 |
| 67 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.30626811 |
| 68 | Abnormal tarsal ossification (HP:0008369) | 2.30330612 |
| 69 | Gangrene (HP:0100758) | 2.29311839 |
| 70 | Vasculitis (HP:0002633) | 2.28996606 |
| 71 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.27874594 |
| 72 | Recurrent cutaneous fungal infections (HP:0011370) | 2.27874594 |
| 73 | Recurrent lower respiratory tract infections (HP:0002783) | 2.27334934 |
| 74 | Osteomyelitis (HP:0002754) | 2.27133114 |
| 75 | Prolonged neonatal jaundice (HP:0006579) | 2.26989425 |
| 76 | Increased IgM level (HP:0003496) | 2.26421490 |
| 77 | Abnormality of iron homeostasis (HP:0011031) | 2.26372284 |
| 78 | Prostate neoplasm (HP:0100787) | 2.24753606 |
| 79 | Hypoplastic ischia (HP:0003175) | 2.24034502 |
| 80 | Disinhibition (HP:0000734) | 2.23564913 |
| 81 | Nausea (HP:0002018) | 2.22583506 |
| 82 | Inappropriate behavior (HP:0000719) | 2.22373558 |
| 83 | Polyneuropathy (HP:0001271) | 2.21696966 |
| 84 | Abnormal foot bone ossification (HP:0010675) | 2.20283191 |
| 85 | Beaking of vertebral bodies (HP:0004568) | 2.19234890 |
| 86 | Abnormality of glycolipid metabolism (HP:0010969) | 2.18653730 |
| 87 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.18653730 |
| 88 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.18653730 |
| 89 | Pulmonary infiltrates (HP:0002113) | 2.18503229 |
| 90 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.17468506 |
| 91 | Recurrent viral infections (HP:0004429) | 2.16994171 |
| 92 | Coxa vara (HP:0002812) | 2.16625068 |
| 93 | Periodontitis (HP:0000704) | 2.14616146 |
| 94 | Basal ganglia calcification (HP:0002135) | 2.13597053 |
| 95 | Thoracolumbar scoliosis (HP:0002944) | 2.11751233 |
| 96 | Flattened epiphyses (HP:0003071) | 2.10531324 |
| 97 | Metaphyseal cupping (HP:0003021) | 2.08339526 |
| 98 | Abnormality of the lumbar spine (HP:0100712) | 2.06883801 |
| 99 | Peritonitis (HP:0002586) | 2.05075021 |
| 100 | Meningitis (HP:0001287) | 2.03639244 |
| 101 | Asymmetric septal hypertrophy (HP:0001670) | 2.00870541 |
| 102 | Parakeratosis (HP:0001036) | 2.00726368 |
| 103 | Malnutrition (HP:0004395) | 2.00464449 |
| 104 | Arthropathy (HP:0003040) | 1.96734920 |
| 105 | Personality changes (HP:0000751) | 1.95559122 |
| 106 | Episodic fever (HP:0001954) | 1.95386336 |
| 107 | Anorexia (HP:0002039) | 1.93604812 |
| 108 | Tetraparesis (HP:0002273) | 1.93482487 |
| 109 | Abnormality of the frontal sinuses (HP:0002687) | 1.93239754 |
| 110 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.92716940 |
| 111 | Arthralgia (HP:0002829) | 1.91406141 |
| 112 | Spondylolisthesis (HP:0003302) | 1.90334291 |
| 113 | Dysostosis multiplex (HP:0000943) | 1.88926713 |
| 114 | Dementia (HP:0000726) | 1.88682303 |
| 115 | Hypergammaglobulinemia (HP:0010702) | 1.86802673 |
| 116 | Glomerulopathy (HP:0100820) | 1.86400380 |
| 117 | Absent epiphyses (HP:0010577) | 1.86127173 |
| 118 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.86127173 |
| 119 | Abnormality of the ischium (HP:0003174) | 1.85859453 |
| 120 | Leukocytosis (HP:0001974) | 1.85533509 |
| 121 | Abnormality of the vertebral endplates (HP:0005106) | 1.84654578 |
| 122 | Supranuclear gaze palsy (HP:0000605) | 1.84180630 |
| 123 | Spontaneous hematomas (HP:0007420) | 1.83741922 |
| 124 | Abnormality of the pericardium (HP:0001697) | 1.83588734 |
| 125 | Neonatal short-limb short stature (HP:0008921) | 1.82848051 |
| 126 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.82496747 |
| 127 | Platyspondyly (HP:0000926) | 1.82462268 |
| 128 | Bone pain (HP:0002653) | 1.82459488 |
| 129 | Petechiae (HP:0000967) | 1.81666039 |
| 130 | Agnosia (HP:0010524) | 1.80453290 |
| 131 | Arterial thrombosis (HP:0004420) | 1.80290486 |
| 132 | Peripheral demyelination (HP:0011096) | 1.80193102 |
| 133 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.79502125 |
| 134 | Hematochezia (HP:0002573) | 1.78749142 |
| 135 | Metaphyseal irregularity (HP:0003025) | 1.78467341 |
| 136 | Increased CSF protein (HP:0002922) | 1.78236128 |
| 137 | Poor head control (HP:0002421) | 1.77902364 |
| 138 | Anhidrosis (HP:0000970) | 1.77828654 |
| 139 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.77374988 |
| 140 | Pathologic fracture (HP:0002756) | 1.77178601 |
| 141 | T lymphocytopenia (HP:0005403) | 1.76818462 |
| 142 | Spinal cord lesions (HP:0100561) | 1.76581534 |
| 143 | Syringomyelia (HP:0003396) | 1.76581534 |
| 144 | Hemoptysis (HP:0002105) | 1.76145297 |
| 145 | Cheilitis (HP:0100825) | 1.75660765 |
| 146 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.74756714 |
| 147 | Abnormality of femoral epiphyses (HP:0006499) | 1.74756714 |
| 148 | Complement deficiency (HP:0004431) | 1.74522554 |
| 149 | Vertigo (HP:0002321) | 1.73188697 |
| 150 | Abnormality of the pleura (HP:0002103) | 1.72330513 |
| 151 | Memory impairment (HP:0002354) | 1.71199878 |
| 152 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.70877730 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 3.89140864 |
| 2 | BLK | 3.76990663 |
| 3 | RIPK4 | 3.22473047 |
| 4 | IRAK3 | 3.10431058 |
| 5 | PBK | 3.10311362 |
| 6 | TBK1 | 3.02317762 |
| 7 | MAP3K3 | 2.70179594 |
| 8 | IRAK4 | 2.63285617 |
| 9 | PIM2 | 2.52482659 |
| 10 | ERN1 | 2.35226554 |
| 11 | MAP4K1 | 2.23356289 |
| 12 | IKBKB | 2.18349685 |
| 13 | NME2 | 2.05940176 |
| 14 | PRPF4B | 1.85558603 |
| 15 | IKBKE | 1.79044660 |
| 16 | MST4 | 1.76868673 |
| 17 | MAP2K3 | 1.69986772 |
| 18 | MAP3K11 | 1.69342383 |
| 19 | TRPM7 | 1.68526122 |
| 20 | STK10 | 1.67105500 |
| 21 | ABL2 | 1.63886657 |
| 22 | BMX | 1.61918468 |
| 23 | RPS6KA4 | 1.56979243 |
| 24 | EPHA2 | 1.53880118 |
| 25 | CSK | 1.53768344 |
| 26 | EPHB1 | 1.53511810 |
| 27 | TYK2 | 1.50904267 |
| 28 | TXK | 1.50400895 |
| 29 | PIM1 | 1.47879416 |
| 30 | JAK3 | 1.44832030 |
| 31 | ERBB3 | 1.44498916 |
| 32 | KIT | 1.41228095 |
| 33 | MST1R | 1.35892277 |
| 34 | CHUK | 1.31263320 |
| 35 | TTN | 1.28743975 |
| 36 | CDC42BPA | 1.27288242 |
| 37 | TESK1 | 1.26192981 |
| 38 | TAOK2 | 1.21752601 |
| 39 | MARK3 | 1.20063773 |
| 40 | TGFBR2 | 1.18372857 |
| 41 | IRAK2 | 1.17192501 |
| 42 | HCK | 1.16603175 |
| 43 | ARAF | 1.12484597 |
| 44 | TEC | 1.11975181 |
| 45 | LRRK2 | 1.11141914 |
| 46 | PRKG2 | 1.11076227 |
| 47 | KDR | 1.10485871 |
| 48 | ADRBK2 | 1.09539476 |
| 49 | ZAP70 | 1.07033970 |
| 50 | BTK | 1.05737946 |
| 51 | JAK1 | 1.03255288 |
| 52 | TRIB3 | 1.03235195 |
| 53 | ACVR1B | 1.02653358 |
| 54 | DDR2 | 1.01310914 |
| 55 | IRAK1 | 0.99685488 |
| 56 | NEK9 | 0.99536626 |
| 57 | FGR | 0.98128715 |
| 58 | TAOK1 | 0.97974016 |
| 59 | LYN | 0.97446737 |
| 60 | CLK1 | 0.90827211 |
| 61 | EIF2AK3 | 0.88046492 |
| 62 | SYK | 0.82279810 |
| 63 | MOS | 0.80315955 |
| 64 | PAK4 | 0.76492952 |
| 65 | LATS2 | 0.76256314 |
| 66 | MAP3K5 | 0.75468526 |
| 67 | LCK | 0.72634486 |
| 68 | MAP3K12 | 0.72291771 |
| 69 | PRKCD | 0.72118004 |
| 70 | PTK6 | 0.71465392 |
| 71 | STK3 | 0.71385168 |
| 72 | ABL1 | 0.70812245 |
| 73 | MET | 0.70715415 |
| 74 | EIF2AK2 | 0.68756680 |
| 75 | MATK | 0.68514841 |
| 76 | CSF1R | 0.65544629 |
| 77 | EGFR | 0.63697250 |
| 78 | SIK3 | 0.63567428 |
| 79 | BMPR2 | 0.61043340 |
| 80 | EPHA3 | 0.60808218 |
| 81 | PDGFRA | 0.56246697 |
| 82 | STK4 | 0.55440072 |
| 83 | JAK2 | 0.54104473 |
| 84 | CAMKK2 | 0.53654739 |
| 85 | RIPK1 | 0.51718328 |
| 86 | ITK | 0.51561997 |
| 87 | STK24 | 0.51497176 |
| 88 | MAP3K13 | 0.51405897 |
| 89 | MAP2K6 | 0.50489390 |
| 90 | MAP3K1 | 0.48705820 |
| 91 | FES | 0.48563913 |
| 92 | PKN2 | 0.46478292 |
| 93 | MAP3K8 | 0.45158447 |
| 94 | MAPK4 | 0.43139235 |
| 95 | PIK3CG | 0.41592391 |
| 96 | ERBB4 | 0.41378714 |
| 97 | GRK7 | 0.40582096 |
| 98 | MAPKAPK2 | 0.39903977 |
| 99 | DAPK2 | 0.37768798 |
| 100 | GSK3A | 0.37405726 |
| 101 | TYRO3 | 0.36755209 |
| 102 | CDK6 | 0.36738033 |
| 103 | DAPK3 | 0.36702595 |
| 104 | MAP3K10 | 0.36365520 |
| 105 | TAOK3 | 0.36308291 |
| 106 | NLK | 0.36106268 |
| 107 | LIMK1 | 0.35812802 |
| 108 | PTK2 | 0.33876197 |
| 109 | RPS6KA6 | 0.32990713 |
| 110 | MAPK7 | 0.32709971 |
| 111 | PDGFRB | 0.31982775 |
| 112 | CAMK1D | 0.31842407 |
| 113 | YES1 | 0.31012145 |
| 114 | GRK6 | 0.30900888 |
| 115 | PDK2 | 0.30787276 |
| 116 | TESK2 | 0.30356607 |
| 117 | DYRK3 | 0.30241095 |
| 118 | HIPK2 | 0.30163917 |
| 119 | INSR | 0.30147414 |
| 120 | PDPK1 | 0.29184928 |
| 121 | RPS6KL1 | 0.28317050 |
| 122 | RPS6KC1 | 0.28317050 |
| 123 | EPHB2 | 0.24901443 |
| 124 | PDK1 | 0.24326666 |
| 125 | PAK1 | 0.23047232 |
| 126 | SIK1 | 0.21733946 |
| 127 | KSR1 | 0.21371290 |
| 128 | KSR2 | 0.20396073 |
| 129 | BRAF | 0.19350253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 3.49064470 |
| 2 | Legionellosis_Homo sapiens_hsa05134 | 2.73027651 |
| 3 | Malaria_Homo sapiens_hsa05144 | 2.69411999 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.61446302 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.48443935 |
| 6 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.46706264 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.44702103 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.39897075 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.38738424 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 2.30053466 |
| 11 | Pertussis_Homo sapiens_hsa05133 | 2.24720020 |
| 12 | Phagosome_Homo sapiens_hsa04145 | 2.21578302 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.18574398 |
| 14 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.09934184 |
| 15 | Salmonella infection_Homo sapiens_hsa05132 | 2.04093859 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.96483270 |
| 17 | Asthma_Homo sapiens_hsa05310 | 1.94070733 |
| 18 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.89903357 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87319243 |
| 20 | Lysosome_Homo sapiens_hsa04142 | 1.85491417 |
| 21 | Shigellosis_Homo sapiens_hsa05131 | 1.74461901 |
| 22 | Allograft rejection_Homo sapiens_hsa05330 | 1.62414488 |
| 23 | Measles_Homo sapiens_hsa05162 | 1.60368267 |
| 24 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.59872291 |
| 25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.57056582 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.51445006 |
| 27 | Apoptosis_Homo sapiens_hsa04210 | 1.50161013 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.46397662 |
| 29 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.46317119 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.45020242 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.44999549 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.42783298 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.41360163 |
| 34 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.40776441 |
| 35 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.38554131 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.36452991 |
| 37 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.27279027 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.25747400 |
| 39 | Amoebiasis_Homo sapiens_hsa05146 | 1.23133794 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.20153822 |
| 41 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.19137914 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.17855697 |
| 43 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.15498376 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.12981711 |
| 45 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.10588023 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.09514415 |
| 47 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07713906 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.07455282 |
| 49 | Viral myocarditis_Homo sapiens_hsa05416 | 1.04712310 |
| 50 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03107100 |
| 51 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.97977013 |
| 52 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97706148 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88147757 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77914739 |
| 55 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.77231077 |
| 56 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.76427932 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.76136044 |
| 58 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75956364 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.75400801 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74675771 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.74391919 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.73348603 |
| 63 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72302881 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.70680885 |
| 65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.69725478 |
| 66 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.68912821 |
| 67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66694041 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64849816 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64329152 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63112476 |
| 71 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62611032 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61907499 |
| 73 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.61176391 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.59301515 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.56343781 |
| 76 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.55243782 |
| 77 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.55240895 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.54838362 |
| 79 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54346120 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.49087090 |
| 81 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.48546249 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.48092382 |
| 83 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47347686 |
| 84 | Prion diseases_Homo sapiens_hsa05020 | 0.47347038 |
| 85 | Mineral absorption_Homo sapiens_hsa04978 | 0.46591919 |
| 86 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.46328026 |
| 87 | HTLV-I infection_Homo sapiens_hsa05166 | 0.46149233 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | 0.44343197 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42616863 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42387748 |
| 91 | Proteasome_Homo sapiens_hsa03050 | 0.41736473 |
| 92 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.38091903 |
| 93 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.37605534 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.36383106 |
| 95 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34191580 |
| 96 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33656749 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.33615439 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.32211864 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.30137380 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.28327521 |
| 101 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.28047499 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.27537165 |
| 103 | Prostate cancer_Homo sapiens_hsa05215 | 0.26042890 |
| 104 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.25649785 |
| 105 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.25462790 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22831075 |
| 107 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.21852162 |
| 108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.20546738 |
| 109 | Insulin resistance_Homo sapiens_hsa04931 | 0.18084123 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.17247764 |
| 111 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.17152799 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14771128 |
| 113 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.14148747 |
| 114 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.13701579 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.13561081 |

